Your browser doesn't support javascript.
loading
Factors leading to dissemination of cutaneous anthrax: an international ID-IRI study.
Elbahr, U S; Tekin, R; Papic, M; Pandak, N; Erdem, H; Can, F K; Alpat, S N; Pekok, A U; Pehlivanoglu, F; Karamese, M; Petru, P C; Kulzhanova, S; Tosun, S; Dogan, M; Moroti, R; Ramosaco, E; Alay, H; Puca, E; Arapovic, J; Pshenichnaya, N; Fasciana, T; Giammanco, A.
Affiliation
  • Elbahr US; Bahrain Oncology Center, King Hamad University Hospital, Department of Infectious Diseases, AlMuharraq, Bahrain.
  • Tekin R; Department of Infectious Diseases, School of Medicine, Dicle University, Diyarbakir, Turkey.
  • Papic M; Libertas International University, Zagreb, Croatia.
  • Pandak N; The Royal Hospital, Muscat, Oman.
  • Erdem H; Bahrain Oncology Center, King Hamad University Hospital, Department of Infectious Diseases, AlMuharraq, Bahrain.
  • Can FK; Department of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Ataturk University, Erzurum, Turkey.
  • Alpat SN; Department of Infectious Disease and Clinical Microbiology, Faculty of Medicine, Eskisehir Osmangazi University, Eskisehir, Turkey.
  • Pekok AU; Department of Infectious Diseases, VM Medical Park, Pendik Hospital, Istanbul, Turkey.
  • Pehlivanoglu F; Department of Clinical Microbiology and Infectious Diseases, University of Health Sciences, Haseki Training and Research Hospital, Istanbul, Turkey.
  • Karamese M; Department of Medical Microbiology, Kafkas University, Kars, Turkey.
  • Petru PC; Dr Victor Babes Clinical Hospital of Infectious and Tropical Diseases, Bucharest, Romania.
  • Kulzhanova S; Department of Infectious Diseases, Astana Medical University, Nur-Sultan, Kazakhstan.
  • Tosun S; Department of Infectious Diseases and Clinical Microbiology, Izmir Bozyaka Training and Research Hospital, Izmir, Turkey.
  • Dogan M; Department of Infectious Diseases, Namik Kemal University School of Medicine, Tekirdag, Turkey.
  • Moroti R; National Institute for Infectious Diseases 'Matei Bals', and 'Carol Davila' University of Medicine and Pharmacy', Bucharest, Romania.
  • Ramosaco E; Infectious Diseases Clinic, University Hospital Center "Mother Teresa", Tirana, Albania.
  • Alay H; Department of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Ataturk University, Erzurum, Turkey.
  • Puca E; Infectious Diseases Clinic, University Hospital Center "Mother Teresa", Tirana, Albania.
  • Arapovic J; Department of Infectious Diseases, University Clinical Hospital Mostar, Mostar, Bosnia and Herzegovina.
  • Pshenichnaya N; Central Research Institute of Epidemiology, Moscow, Russia.
  • Fasciana T; Department of Health Promotion, Maternal-Childhood, Internal Medicine of Excellence G. D'Alessandro, University of Palermo, 90127 Palermo, Italy.
  • Giammanco A; Department of Health Promotion, Maternal-Childhood, Internal Medicine of Excellence G. D'Alessandro, University of Palermo, 90127 Palermo, Italy.
New Microbes New Infect ; 48: 101028, 2022 Jul.
Article in En | MEDLINE | ID: mdl-36193102
ABSTRACT

Background:

Although anthrax is a rare zoonotic infection, it still causes significant mortality and morbidity. In this multicenter study, which is the largest anthrax case series ever reported, we aimed to describe the factors leading to dissemination of cutaneous anthrax.

Methods:

Adult patients with cutaneous anthrax from 16 referral centers were pooled. The study had a retrospective design, and included patients treated between January 1, 1990 and December 1, 2019. Probable, and confirmed cases based upon CDC anthrax 2018 case definition were included in the study. A descriptive statistical analysis was performed for all variables.

Results:

A total of 141 cutaneous anthrax patients were included. Of these, 105 (74%) patients had probable and 36 (26%) had confirmed diagnosis. Anthrax meningitis and bacteremia occurred in three and six patients, respectively. Sequelae were observed in three patients cicatricial ectropion followed by ocular anthrax (n = 2) and movement restriction on the left hand after surgical intervention (n = 1). One patient had gastrointestinal anthrax. The parameters related to poor outcome (p < 0.05) were fever, anorexia, hypoxia, malaise/fatigue, cellulitis, fasciitis, lymphadenopathy, leukocytosis, high CRP and creatinine levels, longer duration of antimicrobial therapy, and combined therapy. The last two were seemingly the consequences of dissemination rather than being the reasons. The fatality rate was 1.4%.

Conclusions:

Rapid identification of anthrax is crucial for prompt and effective treatment. Systemic symptoms, disseminated local infection, and high inflammatory markers should alert the treating physicians for the dissemination of the disease.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials / Prognostic_studies Language: En Journal: New Microbes New Infect Year: 2022 Document type: Article Affiliation country: Bahrain

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials / Prognostic_studies Language: En Journal: New Microbes New Infect Year: 2022 Document type: Article Affiliation country: Bahrain